DPP-4 inhibitors for the treatment of type 2 diabetes: a methodology overview of systematic reviews

被引：0
|
作者：
Juan Ling
Long Ge
Ding-hua Zhang
Yong-feng Wang
Zhuo-lin Xie
Jin-hui Tian
Xiao-hui Xiao
Ke-hu Yang
机构：
[1] Lanzhou University,School of Basic Medical Sciences, Evidence
[2] Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province,Based Medicine Center
[3] Lanzhou University,Chinese GRADE Center
[4] WHO Collaborating Center for Guideline Implementation and Knowledge Translation,School of Basic Medical Sciences
[5] The First Clinical Medical College of Lanzhou University,Department of Endocrinology
[6] Gansu University of Traditional Chinese Medicine,undefined
[7] Gansu University of Traditional Chinese Medicine,undefined
[8] Gansu Province Hospital of Traditional Chinese Medicine,undefined
[9] Gansu Provincial People’s Hospital,undefined
来源：
Acta Diabetologica | 2019年 / 56卷
关键词：
Dipeptidyl peptidase 4 inhibitors; Systematic reviews; Type 2 diabetes mellitus; AMSTAR; GRADE;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：7 / 27
页数：20
相关论文
共 50 条
  • [41] Novel combination treatment of type 2 diabetes DPP-4 inhibition
    Ahren, Bo
    VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (02) : 383 - 394
  • [42] Design and synthesis of DPP-4 inhibitor for the treatment of type 2 diabetes
    Peng Cho Tang
    Chinese Chemical Letters, 2010, 21 (03) : 253 - 256
  • [43] Design and synthesis of DPP-4 inhibitor for the treatment of type 2 diabetes
    Tang, Peng Cho
    Lin, Zhi Gang
    Wang, Yang
    Yang, Fang Long
    Wang, Qian
    Fu, Jian Hong
    Zhang, Lei
    Gong, Ai Shen
    Luo, Jing Jing
    Dai, Jun
    She, Gao Hong
    Si, Dan Dan
    Feng, Jun
    CHINESE CHEMICAL LETTERS, 2010, 21 (03) : 253 - 256
  • [44] NATIONAL COUNCIL OF EXPERTS: THE PLACE OF DPP-4 INHIBITORS IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Shestakova, Marina V.
    Vagapova, Gulnar R.
    Vikulova, Olga K.
    Galstyan, Gagik R.
    Demidova, Tatiana Y.
    Dudinskaya, Ekaterina N.
    Kiseleva, Tatiana P.
    Mkrtumyan, Ashot M.
    Petunina, Nina A.
    Tkacheva, Olga N.
    Fadeev, Valentin V.
    Khalimov, Yuriy S.
    Shestakova, Ekaterina A.
    DIABETES MELLITUS, 2023, 26 (06): : 619 - 625
  • [45] Discovery of Novel Tricyclic Heterocycles as Potent and Selective DPP-4 Inhibitors for the Treatment of Type 2 Diabetes
    Wu, Wen-Lian
    Hao, Jinsong
    Domalski, Martin
    Burnett, Duane A.
    Pissarnitski, Dmitri
    Zhao, Zhiqiang
    Stamford, Andrew
    Scapin, Giovanna
    Gao, Ying-Duo
    Soriano, Aileen
    Kelly, Terri M.
    Yao, Zuliang
    Powles, Mary Ann
    Chen, Shiying
    Mei, Hong
    Hwa, Joyce
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (05): : 498 - 501
  • [46] Treatment for Type-2-Diabetes News: Fixed Combination of DPP-4 and SGLT-2 Inhibitors
    不详
    DIABETES STOFFWECHSEL UND HERZ, 2018, 27 (03): : 157 - 158
  • [47] Healthcare Costs Among Adults with Type 2 Diabetes Initiating DPP-4 Inhibitors
    Amanda M. Farr
    John J. Sheehan
    Matthew Brouillette
    David M. Smith
    Stephen S. Johnston
    Iftekhar Kalsekar
    Advances in Therapy, 2016, 33 : 68 - 81
  • [48] The Effects of DPP-4 Inhibitors on Plasma Catecholamines and Their Metabolites in Patients with Type 2 Diabetes
    Park, Ie Byung
    Lee, Daeho
    Lee, Kiyoung
    DIABETES, 2019, 68
  • [49] THE ROLE OF DPP-4 INHIBITORS IN ANGIOGENESIS IN DIABETES
    Chan, Jenq-Shyong
    Wu, Tao-Cheng
    Chen, Jaw-Wen
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 171 - 172
  • [50] DPP-4 inhibitors, heart failure and type 2 diabetes: all eyes on safety
    Paneni, Francesco
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2015, 5 (06) : 471 - 478
12345